coronavirus - International Biopharmaceutical Industry

news

Sanofi and GSK, after delays, to seek clearance for COVID-19 vaccine

Sanofi and GlaxoSmithKline plan to seek authorization for their experimental coronavirus vaccine in the U.S. and abroad after their shot prevented COVID-19 in a large...

24 February 2022 news coronavirus | COVID-19

Continue Reading →

news

Omicron cuts Pfizer vaccine’s potency, but data show booster may restore protection

Three doses of Pfizer and BioNTech's COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus str...

10 December 2021 news BioNTech | booster

Continue Reading →

news

Vaccine makers move quickly to confront omicron threat

Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant. Facing a coronavirus variant t...

3 December 2021 news coronavirus | drugmakers

Continue Reading →

news

FDA advisers support Pfizer’s coronavirus vaccine for young children

A group of advisers to the Food and Drug Administration on Tuesday endorsed use of Pfizer's coronavirus vaccine in younger children, judging the benefits of the shot ...

29 October 2021 news cases | coronavirus

Continue Reading →

news

After coronavirus success, J&J hits setback with HIV vaccine

Before J&J become one of three companies that earned Food and Drug Administration approval for a coronavirus vaccine, the pharma was already a leader in vaccine d...

3 September 2021 news coronavirus | drugmaker

Continue Reading →

news

Moderna says vaccine protective through six months, but warns boosters needed this fall

Like Pfizer, Moderna is pressing the case for booster shots, although public health officials and experts have not yet agreed on when an additional dose would be need...

13 August 2021 news boosters | coronavirus

Continue Reading →